NeoGenomics, Inc. Share-based Payment Arrangement, Expense
NeoGenomics, Inc. (NEO) reported Share-based Payment Arrangement, Expense of $8.22 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-07-28
- NeoGenomics, Inc. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $8.22M, a 32.74% decline year-over-year.
- NeoGenomics, Inc. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $9.64M, a 10.40% decline year-over-year.
- NeoGenomics, Inc. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $8.04M, a 3.43% decline year-over-year.
- NeoGenomics, Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $10.30M, a 21.66% increase year-over-year.
- NeoGenomics, Inc. share-based payment arrangement, expense for fiscal 2025 was $41.32M, a 23.65% increase from fiscal 2024.
- NeoGenomics, Inc. share-based payment arrangement, expense for fiscal 2024 was $33.41M, a 35.64% increase from fiscal 2023.
- NeoGenomics, Inc. share-based payment arrangement, expense for fiscal 2023 was $24.63M, a 0.16% decline from fiscal 2022.
- NeoGenomics, Inc. share-based payment arrangement, expense for fiscal 2022 was $24.67M, a 9.65% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 9 month as first filed | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $8.22M 10-Q · filed 2026-07-28 | $17.85M 10-Q · filed 2026-07-28 | $25.89M derived: sum of 3 quarters · filed 2026-07-28 | $36.20M derived: sum of 4 quarters · filed 2026-07-28 | ||||
| 2026-03-31 | $9.64M 10-Q · filed 2026-04-28 | $17.68M derived: sum of 2 quarters · filed 2026-04-28 | $27.98M derived: sum of 3 quarters · filed 2026-04-28 | $40.20M derived: sum of 4 quarters · filed 2026-07-28 | ||||
| 2025-12-31 | $8.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $18.35M derived: sum of 2 quarters · filed 2026-02-17 | $30.56M derived: sum of 3 quarters · filed 2026-07-28 | $41.32M 10-K · filed 2026-02-17 | ||||
| 2025-09-30 | $10.30M 10-Q · filed 2025-10-28 | $22.52M derived: sum of 2 quarters · filed 2026-07-28 | $33.27M 10-Q · filed 2025-10-28 | $41.60M derived: sum of 4 quarters · filed 2026-07-28 | ||||
| 2025-06-30 | $12.21M 10-Q · filed 2026-07-28 | $22.97M 10-Q · filed 2026-07-28 | $31.30M derived: sum of 3 quarters · filed 2026-07-28 | $39.77M derived: sum of 4 quarters · filed 2026-07-28 | ||||
| 2025-03-31 | $10.75M 10-Q · filed 2026-04-28 | $19.08M derived: sum of 2 quarters · filed 2026-04-28 | $27.55M derived: sum of 3 quarters · filed 2026-04-28 | $36.39M derived: sum of 4 quarters · filed 2026-04-28 | ||||
| 2024-12-31 | $8.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $16.80M derived: sum of 2 quarters · filed 2026-02-17 | $25.64M derived: sum of 3 quarters · filed 2026-02-17 | $33.41M 10-K · filed 2026-02-17 | ||||
| 2024-09-30 | $8.47M 10-Q · filed 2025-10-28 | $17.31M derived: sum of 2 quarters · filed 2025-10-28 | $25.09M 10-Q · filed 2025-10-28 | $32.08M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-06-30 | $8.84M 10-Q · filed 2025-07-29 | $16.61M 10-Q · filed 2025-07-29 | $23.61M derived: sum of 3 quarters · filed 2026-02-17 | $30.79M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-03-31 | $7.77M 10-Q · filed 2025-04-29 | $14.76M derived: sum of 2 quarters · filed 2026-02-17 | $21.94M derived: sum of 3 quarters · filed 2026-02-17 | $27.65M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2023-12-31 | $6.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $14.17M derived: sum of 2 quarters · filed 2026-02-17 | $19.88M derived: sum of 3 quarters · filed 2026-02-17 | $24.63M 10-K · filed 2026-02-17 | $24.60M 10-K · filed 2024-02-20 | |||
| 2023-09-30 | $7.18M 10-Q · filed 2024-11-05 | $7.20M 10-Q · filed 2023-11-06 | $12.88M derived: sum of 2 quarters · filed 2024-11-05 | $17.64M 10-Q · filed 2024-11-05 | $17.60M 10-Q · filed 2023-11-06 | $22.32M derived: sum of 4 quarters · filed 2025-02-18 | ||
| 2023-06-30 | $5.71M 10-Q · filed 2024-07-30 | $5.70M 10-Q · filed 2023-08-08 | $10.46M 10-Q · filed 2024-07-30 | $10.50M 10-Q · filed 2023-08-08 | $15.13M derived: sum of 3 quarters · filed 2025-02-18 | $19.43M derived: sum of 4 quarters · filed 2025-02-18 | ||
| 2023-03-31 | $4.76M 10-Q · filed 2024-04-30 | $4.80M 10-Q · filed 2023-05-09 | $9.43M derived: sum of 2 quarters · filed 2025-02-18 | $13.73M derived: sum of 3 quarters · filed 2025-02-18 | $17.33M derived: sum of 4 quarters · filed 2025-02-18 | |||
| 2022-12-31 | $4.67M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $8.97M derived: sum of 2 quarters · filed 2025-02-18 | $12.57M derived: sum of 3 quarters · filed 2025-02-18 | $24.67M 10-K · filed 2025-02-18 | $24.70M 10-K · filed 2024-02-20 | |||
| 2022-09-30 | $4.30M 10-Q · filed 2023-11-06 | $7.90M derived: sum of 2 quarters · filed 2023-11-06 | $20.00M 10-Q · filed 2023-11-06 | $30.10M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2022-06-30 | $3.60M 10-Q · filed 2023-08-08 | $15.70M 10-Q · filed 2023-08-08 | $25.80M derived: sum of 3 quarters · filed 2024-02-20 | $31.00M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2022-03-31 | $12.10M 10-Q · filed 2023-05-09 | $22.20M derived: sum of 2 quarters · filed 2024-02-20 | $27.40M derived: sum of 3 quarters · filed 2024-02-20 | $31.90M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2021-12-31 | $10.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $15.30M derived: sum of 2 quarters · filed 2024-02-20 | $19.80M derived: sum of 3 quarters · filed 2024-02-20 | $22.50M 10-K · filed 2024-02-20 | ||||
| 2021-09-30 | $5.20M 10-Q · filed 2022-11-08 | $9.70M derived: sum of 2 quarters · filed 2022-11-08 | $12.40M 10-Q · filed 2022-11-08 | |||||
| 2021-06-30 | $4.50M 10-Q · filed 2022-08-09 | $7.20M 10-Q · filed 2022-08-09 | ||||||
| 2021-03-31 | $2.70M 10-Q · filed 2022-05-09 | |||||||
| 2020-09-30 | $2.70M 10-Q · filed 2021-11-04 | $5.30M derived: sum of 2 quarters · filed 2021-11-04 | $7.50M 10-Q · filed 2021-11-04 | |||||
| 2020-06-30 | $2.60M 10-Q · filed 2021-08-09 | $4.80M 10-Q · filed 2021-08-09 | ||||||
| 2020-03-31 | $2.20M 10-Q · filed 2021-05-06 | |||||||
| 2019-09-30 | $3.30M 10-Q · filed 2020-10-29 | $5.60M derived: sum of 2 quarters · filed 2020-10-29 | $7.70M 10-Q · filed 2020-10-29 | |||||
| 2019-06-30 | $2.30M 10-Q · filed 2020-07-31 | $4.50M 10-Q · filed 2020-07-31 | ||||||
| 2019-03-31 | $2.10M 10-Q · filed 2020-04-29 | |||||||
| 2018-09-30 | $1.10M 10-Q · filed 2019-11-13 | $3.50M derived: sum of 2 quarters · filed 2019-11-13 | $5.00M 10-Q · filed 2019-11-13 | |||||
| 2018-06-30 | $2.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $4.00M 10-Q · filed 2019-08-07 | ||||||
| 2018-03-31 | $1.60M 10-Q · filed 2019-05-08 | |||||||
| 2017-09-30 | $2.80M 10-Q · filed 2018-11-06 | $5.80M 10-Q · filed 2018-11-06 | ||||||
| 2015-09-30 | $828.00K 10-Q · filed 2015-11-06 | $1.34M derived: sum of 2 quarters · filed 2015-11-06 | $1.73M 10-Q · filed 2015-11-06 | |||||
| 2015-06-30 | $508.00K 10-Q · filed 2015-07-31 | $813.00K 10-Q · filed 2015-07-31 | ||||||
| 2015-03-31 | $342.00K 10-Q · filed 2015-05-11 | |||||||
| 2014-09-30 | $320.00K 10-Q · filed 2015-11-06 | $477.00K derived: sum of 2 quarters · filed 2015-11-06 | $566.00K 10-Q · filed 2015-11-06 | |||||
| 2014-06-30 | $157.00K 10-Q · filed 2015-07-31 | $246.00K 10-Q · filed 2015-07-31 | ||||||
| 2014-03-31 | $89.00K 10-Q · filed 2015-05-11 | |||||||
| 2012-12-31 | $575.00K 10-K · filed 2013-02-21 | |||||||
| 2011-12-31 | $285.00K 10-K · filed 2013-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |